1-4 of 4
Koichi Hirata
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Novel Correlation between LINE-1 Hypomethylation and the Malignancy of Gastrointestinal Stromal Tumors

Shinichi Igarashi, Hiromu Suzuki, Takeshi Niinuma, Haruo Shimizu, Masanori Nojima, Hiroyuki Iwaki, Takayuki Nobuoka, Toshirou Nishida, Yasuaki Miyazaki, Hiroyuki Takamaru, Eiichiro Yamamoto, Hiroyuki Yamamoto, Takashi Tokino, Tadashi Hasegawa, Koichi Hirata, Kohzoh Imai, Minoru Toyota, Yasuhisa Shinomura
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (21): 5114–5123.
https://doi.org/10.1158/1078-0432.CCR-10-0581
Published: 31 October 2010
View article titled, A Novel Correlation between <em>LINE-1</em> Hypomethylation and the Malignancy of Gastrointestinal Stromal Tumors
Open the PDF for A Novel Correlation between <em>LINE-1</em> Hypomethylation and the Malignancy of Gastrointestinal Stromal Tumors in another window
Includes: Supplementary data
Journal Articles

A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins

Satomi Idenoue, Yoshihiko Hirohashi, Toshihiko Torigoe, Yuriko Sato, Yasuaki Tamura, Hiroyuki Hariu, Masaaki Yamamoto, Takehiro Kurotaki, Tetsuhiro Tsuruma, Hiroko Asanuma, Takayuki Kanaseki, Hideyuki Ikeda, Kiyoteru Kashiwagi, Minoru Okazaki, Kazuaki Sasaki, Takashi Sato, Tousei Ohmura, Fumitake Hata, Koji Yamaguchi, Koichi Hirata, Noriyuki Sato
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (4): 1474–1482.
https://doi.org/10.1158/1078-0432.CCR-03-0817
Published: 02 March 2005
View article titled, A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins
Open the PDF for A Potent Immunogenic General Cancer Vaccine That Targets Survivin, an Inhibitor of Apoptosis Proteins in another window
Journal Articles

Combination Phase I Trial of a Novel Oral Fluorouracil Derivative S-1 with Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27–9902)

Bunzo Nakata, Yasushi Mitachi, Akihito Tsuji, Susumu Yamamitsu, Koichi Hirata, Tetsuhiko Shirasaka, Kosei Hirakawa
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (5): 1664–1669.
https://doi.org/10.1158/1078-0432.CCR-03-0045
Published: 10 March 2004
View article titled, Combination Phase I Trial of a Novel Oral Fluorouracil Derivative S-1 with Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27–9902)
Open the PDF for Combination Phase I Trial of a Novel Oral Fluorouracil Derivative S-1 with Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27–9902) in another window
Journal Articles

Pharmacokinetic Study of S-1, a Novel Oral Fluorouracil Antitumor Drug

Koichi Hirata, Noboru Horikoshi, Keisuke Aiba, Minoru Okazaki, Ryuichi Denno, Kazuaki Sasaki, Yasuyuki Nakano, Hikaru Ishizuka, Yasuhide Yamada, Shinji Uno, Tetsuo Taguchi, Tetsuhiko Shirasaka
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (8): 2000–2005.
Published: 01 August 1999
View article titled, Pharmacokinetic Study of S-1, a Novel Oral Fluorouracil Antitumor Drug
Open the PDF for Pharmacokinetic Study of S-1, a Novel Oral Fluorouracil Antitumor Drug in another window